FDA transparency rules could hit small companies hardest

Nat Biotechnol. 2010 Aug;28(8):767-8. doi: 10.1038/nbt0810-767a.
No abstract available

Publication types

  • News

MeSH terms

  • Biotechnology / standards*
  • Confidentiality
  • Drug Industry / standards*
  • Drug Labeling / standards*
  • United States
  • United States Food and Drug Administration